These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3931296)

  • 1. Modified anti-C3 immune complex assay which avoids interference by anti-F(ab')2 antibodies.
    Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1985 Jul; 146(3):337-47. PubMed ID: 3931296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating immune complexes with polyethylene glycol precipitation F(ab')2 anti-C3 ELISA.
    Xu RJ; Gu YA
    J Immunol Methods; 1990 Dec; 135(1-2):225-31. PubMed ID: 2273258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-F(ab')2 antibodies that interfere with interpretation of the anti-C3 assay for immune complexes in children with rheumatic diseases.
    Olds LC; Miller JJ
    Arthritis Rheum; 1984 Mar; 27(3):330-6. PubMed ID: 6704194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative immunoassay for IgA class circulating immune complexes using solid phase Facb fragment of anti-C3.
    Hosoda K; Sakurabayashi I; Kawai T; Suzuki H; Maeda M; Tsuji A
    J Immunol Methods; 1985 Oct; 82(2):243-52. PubMed ID: 3900216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
    Bruneau C; Bonin H
    Clin Exp Immunol; 1983 Sep; 53(3):529-35. PubMed ID: 6616954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of circulating immune complexes in human serum by the Raji cell and F(ab')2 anti-C3 micro enzyme immunoassays.
    Jordan SC; Gautier E; Sakai R; Bahn L
    J Immunol Methods; 1985 Nov; 83(2):363-70. PubMed ID: 3902980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anti-F (ab')2 antibodies (pepsin agglutinators) with immune complexes as determined by enzyme-linked immunosorbent assays.
    Davey MP; Korngold L
    Int Arch Allergy Appl Immunol; 1982; 67(3):278-83. PubMed ID: 6977496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active systemic lupus erythematosus is associated with depletion of the natural generic anti-idiotype (anti-F(ab')2) system.
    Williams RC; Malone CC; Huffman GR; Silvestris F; Croker BP; Ayoub EM; Massengill S
    J Rheumatol; 1995 Jun; 22(6):1075-85. PubMed ID: 7674233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallelism of serum anti-F(ab')2 and anti-cationic IgG reactivities in patients with systemic lupus erythematosus.
    Silvestris F; Yancey WB; Malone C; Searles R; Dammacco F; Williams RC
    Clin Immunol Immunopathol; 1991 May; 59(2):256-70. PubMed ID: 2009644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
    Lutz HU; Fumia S
    Autoimmun Rev; 2008 Jun; 7(6):508-13. PubMed ID: 18558371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The measurement of IgG class circulating immune complexes in liver diseases using F(ab')2 anti C3 ELISA].
    Muratsugu M; Makino M; Kohda H; Sekiya C
    Rinsho Byori; 1987 Dec; 35(12):1385-91. PubMed ID: 3502152
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of circulating immune complex levels by ELISA using F(ab')2 anti-C3 antibody].
    Muratsugu M; Makino M
    Rinsho Byori; 1986 Oct; Spec No 69():53-9. PubMed ID: 3806992
    [No Abstract]   [Full Text] [Related]  

  • 14. Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.
    Fumia S; Goede JS; Fischler M; Luginbühl A; Frick S; Fodor P; Lutz HU
    Mol Immunol; 2008 May; 45(10):2951-61. PubMed ID: 18339427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixation of complement by anti-F(ab')2 antibodies or ssDNA when added to systemic lupus erythematosus sera.
    Shrier DA; Taniguchi O; Barnett EV
    J Rheumatol; 1984 Apr; 11(2):182-7. PubMed ID: 6610052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactivity of human IgG anti-F(ab')2 antibody with DNA and other nuclear antigens.
    Williams RC; Malone CC; Cimbalnik K; Presley MA; Roux KH; Strelets L; Silvestris F
    Arthritis Rheum; 1997 Jan; 40(1):109-23. PubMed ID: 9008607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
    Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
    J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
    Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
    Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems in the detection of complement-fixing immune complexes.
    Rødahl E
    Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):125-30. PubMed ID: 3875968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3-containing serum immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic diseases.
    Huber C; Rüger A; Herrmann M; Krapf F; Kalden JR
    Rheumatol Int; 1989; 9(2):59-64. PubMed ID: 2814209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.